Table 1 Demographics and clinical information

From: Magnetic seizure therapy reduces suicidal ideation and produces neuroplasticity in treatment-resistant depression

Category Value
Sample size 23
Sex, no. (%)
 Male 11 (49)
 Female 12 (51)
Age, mean (SD), years 45.0 (12.2)
Illness duration, mean (SD), years 20.7 (15.0)
No. of depressive episodes, mean (SD)a 8.3 (11.3)
ATHF (cumulative score for current episode), mean (SD) 11.6 (7.6)
Medication, n: dose (mg) Antidepressant:
Bupropion, 5: (300, 300, 300, 300, 450)
Duloxetine, 4: (120, 60, 120, 120)
Trazodone, 4: (50, 100, 50, 100)
Desvenlafaxine, 3: (50, 150, 100)
Escitalopram, 3: (40, 20, 35)
Quetiapine, 3: (50, 300, 150)
Fluoxetine, 2: (120, 60)
Sertraline, 2: (100, 100)
Mirtazapine, 1: (45)
Nortriptyline, 1: (75)
Venlafaxine, 1: (225)
Antipsychotic:
Aripiprazole, 2: (300, 10)
Risperidone, 2: (2, 4)
Benzodiazepine:
Clonazepam, 5: (0.25, 1, 1, 0.5, 1)
Lorazepam, 4: (1, 1.5, 0.5, 0.5)
Zopiclone, 2: (7.5, 7.5)
Diazepam, 1: (20)
Others:
Lithium, 1: (450)
Pregabalin, 1: (150)
  1. aInformation was only available from 13 patients, 9 had too many episodes to keep track, and 1 patient had indeterminate number of episodes.